Diabetic foot ulcers (DFUs) remain one of the most challenging and costly complications of diabetes, with significant implications for patient health and healthcare systems worldwide. A recent narrative review published in Medicina sheds light on the potential role of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-Is) in preventing and managing diabetic foot complications. While these medications are primarily known... Continue Reading →